Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report

Saved in:
Bibliographic Details
Title: Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report
Authors: Rossing, Henrik H.1 Henrik.Holm.Rossing@regionh.dk, Grauslund, Morten1 Morten.Grauslund@regionh.dk, Urbanska, Edyta M.2 Edyta.Maria.Urbanska@regionh.dk, Melchior, Linea C.1 Linea.Cecilie.Melchior@regionh.dk, Rask, Charlotte K.3 Charlotte.Krogh.Rask@regionh.dk, Costa, Junia C.4 Junia.Cardosa.Costa@regionh.dk, Skov, Birgit G.5 Birgit.Guldhammer.Skov.01@regionh.dk, Sørensen, Jens Benn2 Jens.Benn.Soerensen@regionh.dk, Santoni-Rugiu, Eric1 Eric.Santoni-Rugiu.02@regionh.dk
Source: BMC Research Notes. 2013, Vol. 6 Issue 1, p1-17. 17p. 2 Color Photographs, 1 Black and White Photograph, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:17560500
DOI:10.1186/1756-0500-6-489